Why UnitedHealth Group’s Shares Have Taken a Tumble
UnitedHealth Group's shares fell by over 22% on Thursday after its first quarter earnings. This is largely due to challenges in its Medicare Advantage business.
The Big 3 PBMs are Countersuing the FTC. Does Their Argument Have Any Teeth?
After the FTC filed a lawsuit in September, accusing the three major pharmacy benefit managers of anticompetitive rebating practices related to insulin, the defendants reversed roles and became plaintiffs. In November, they countersued the agency, arguing that its lawsuit is unconstitutional.
presented by
The Best Options for Diagnostic Imaging Covered by Medicare
Health care professionals can refer patients to the best options for diagnostic imaging covered by Medicare to give more people the medical assistance they need without extra financial stress.
Why the DOJ’s Lawsuit Against the UGH-Amedisys Merger May Not Go Anywhere
Experts aren’t sure what the outcome of the DOJ’s recent lawsuit against the proposed UnitedHealth Group/Amedisys merger will be under the incoming Trump administration. The Biden administration has focused more on supporting clinicians, while the previous Trump administration favored corporations. Additionally, one expert noted that this case differs from other antitrust lawsuits because it does not seem to focus on a potential price increase.